Patents by Inventor Philip N. Borer

Philip N. Borer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9193968
    Abstract: The present invention provides improved aptamer libraries useful for discovery of aptamers that have high binding affinity for a single or a plurality of targets. The libraries contain higher copies of each member candidate such that they are more likely to be available to the application of acyclic identification methods that obviate the most time-consuming and costly step in traditional SELEX method, the multiple cycles of evolutionary selection.
    Type: Grant
    Filed: March 1, 2011
    Date of Patent: November 24, 2015
    Assignee: APTAMATRIX, INC.
    Inventors: Philip N. Borer, Mark P. McPike
  • Publication number: 20150259673
    Abstract: The present invention provides improved aptamer libraries useful for discovery of aptamers that have high binding affinity for a single or a plurality of targets. The libraries contain higher copies of each member candidate such that they are more likely to be available to the application of acyclic identification methods that obviate the most time-consuming and costly step in traditional SELEX method, the multiple cycles of evolutionary selection.
    Type: Application
    Filed: March 1, 2011
    Publication date: September 17, 2015
    Inventors: Philip N. Borer, Mark P. McPike
  • Patent number: 8921278
    Abstract: A method is disclosed to obtain oligonucleotide sequences with high affinity to target molecules. By design, the oligonucleotides have a defined primary and secondary structure. The affinity for binding to target species is classified or quantified by assay measurements using physical measurements rather than being based primarily on separations. Targets include but are not limited to proteins, polymers, biological membranes including cells and organelles and small molecules.
    Type: Grant
    Filed: March 23, 2006
    Date of Patent: December 30, 2014
    Assignee: Syracuse University
    Inventors: Bruce S. Hudson, Philip N. Borer
  • Publication number: 20130217582
    Abstract: The present invention provides improved aptamer libraries useful for discovery of aptamers that have high binding affinity for a single or a plurality of targets. The libraries contain higher copies of each member candidate such that they are more likely to be available to the application of acyclic identification methods that obviate the most time-consuming and costly step in traditional SELEX method, the multiple cycles of evolutionary selection.
    Type: Application
    Filed: March 1, 2011
    Publication date: August 22, 2013
    Inventors: Philip N. Borer, Mark P. McPike
  • Patent number: 8080379
    Abstract: Embodiments of the invention relate to a branched or multichain nucleic acid switch adapted to switch from a first conformation to a second conformation upon ligand binding. The switch includes a probe strand, P, which includes the ligand binding domain; a switching framework which includes a cover strand (C), and a tether that holds P and C together and a signaling apparatus. Some embodiments include a toggle strand (T) where now the tether holds P, C, T, and the signaling apparatus together. As the switch changes between the first and second conformations; the signaling apparatus reports the state of the switch. The signaling entity is typically a lumiphore and a quencher located along the switching framework. Nucleic acid switches have applications in real time assays for diverse agents including infectious agents, environmental toxins, and terrorist agents, as well as screening methods for such agents. Further applications are found for nanoelectronics, nanofabrication and nanomachines.
    Type: Grant
    Filed: October 11, 2010
    Date of Patent: December 20, 2011
    Assignee: Syracuse University
    Inventors: Philip N. Borer, Bruce S. Hudson
  • Publication number: 20110263459
    Abstract: The present invention provides aptamer libraries with pre-defined secondary structures that can be used for oversampled screening for affinity binding.
    Type: Application
    Filed: March 12, 2009
    Publication date: October 27, 2011
    Inventors: Philip N. Borer, Mark P. McPike
  • Publication number: 20110059555
    Abstract: Embodiments of the invention relate to a branched or multichain nucleic acid switch adapted to switch from a first conformation to a second conformation upon ligand binding. The switch includes a probe strand, P, which includes the ligand binding domain; a switching framework which includes a cover strand (C), and a tether that holds P and C together and a signaling apparatus. Some embodiments include a toggle strand (T) where now the tether holds P, C, T, and the signaling apparatus together. As the switch changes between the first and second conformations; the signaling apparatus reports the state of the switch. The signaling entity is typically a lumiphore and a quencher located along the switching framework. Nucleic acid switches have applications in real time assays for diverse agents including infectious agents, environmental toxins, and terrorist agents, as well as screening methods for such agents. Further applications are found for nanoelectronics, nanofabrication and nanomachines.
    Type: Application
    Filed: October 11, 2010
    Publication date: March 10, 2011
    Applicant: Syracuse University
    Inventors: Philip N. Borer, Bruce S. Hudson
  • Patent number: 7829287
    Abstract: Embodiments of the invention relate to a branched or multichain nucleic acid switch adapted to switch from a first conformation to a second conformation upon ligand binding. The switch includes a probe strand, P, which includes the ligand binding domain; a switching framework which includes a cover strand (C), and a tether that holds P and C together and a signaling apparatus. Some embodiments include a toggle strand (T) where now the tether holds P, C, T, and the signaling apparatus together. As the switch changes between the first and second conformations; the signaling apparatus reports the state of the switch. The signaling entity is typically a lumiphore and a quencher located along the switching framework. Nucleic acid switches have applications in real time assays for diverse agents including infectious agents, environmental toxins, and terrorist agents, as well as screening methods for such agents. Further applications are found for nanoelectronics, nanofabrication and nanomachines.
    Type: Grant
    Filed: March 10, 2009
    Date of Patent: November 9, 2010
    Assignee: Syracuse University
    Inventors: Philip N. Borer, Bruce S. Hudson
  • Patent number: 7718784
    Abstract: In one embodiment, the present invention relates to fluorescent nucleic acid constructs and methods of using these switchable constructs to rapidly screen for target molecule interactions. More particularly, an RNA/DNA chimera comprising a fluorophore-quencher pair and a nucleic acid construct is disclosed for the rapid screening of interactions between the HIV-1 nucleocapsid protein, NCp7, and a stem-loop region, SL3, of the HIV-1 RNA, or antagonists thereof. The compositions and methods disclosed herein can be used in preferred aspects of the present invention for diagnosing disease states, distinguishing the presence of infectious or toxic agents, drug discovery and design, and molecular electronic applications.
    Type: Grant
    Filed: February 3, 2004
    Date of Patent: May 18, 2010
    Assignee: Syracuse University
    Inventors: Philip N. Borer, Bruce S. Hudson, Christopher L. DeCiantis
  • Publication number: 20090203025
    Abstract: Embodiments of the invention relate to a branched or multichain nucleic acid switch adapted to switch from a first conformation to a second conformation upon ligand binding. The switch includes a probe strand, P, which includes the ligand binding domain; a switching framework which includes a cover strand (C), and a tether that holds P and C together and a signaling apparatus. Some embodiments include a toggle strand (T) where now the tether holds P, C, T, and the signaling apparatus together. As the switch changes between the first and second conformations; the signaling apparatus reports the state of the switch. The signaling entity is typically a lumiphore and a quencher located along the switching framework. Nucleic acid switches have applications in real time assays for diverse agents including infectious agents, environmental toxins, and terrorist agents, as well as screening methods for such agents. Further applications are found for nanoelectronics, nanofabrication and nanomachines.
    Type: Application
    Filed: March 10, 2009
    Publication date: August 13, 2009
    Applicant: Syracuse University
    Inventors: Philip N. Borer, Bruce S. Hudson
  • Patent number: 7521546
    Abstract: Embodiments of the invention relate to a branched or multichain nucleic acid switch adapted to switch from a first conformation to a second conformation upon ligand binding. The switch includes a probe strand, P, which includes the ligand binding domain; a switching framework which includes a cover strand (C), and a tether that holds P and C together and a signaling apparatus. Some embodiments include a toggle strand (T) where now the tether holds P, C, T, and the signaling apparatus together. As the switch changes between the first and second conformations; the signaling apparatus reports the state of the switch. The signaling entity is typically a lumiphore and a quencher located along the switching framework. Nucleic acid switches have applications in real time assays for diverse agents including infectious agents, environmental toxins, and terrorist agents, as well as screening methods for such agents. Further applications are found for nanoelectronics, nanofabrication and nanomachines.
    Type: Grant
    Filed: August 2, 2005
    Date of Patent: April 21, 2009
    Assignee: Syracuse University
    Inventors: Philip N. Borer, Bruce S. Hudson
  • Patent number: 7075303
    Abstract: A nuclear magnetic resonance (NMR) sample tube is made of a polymeric material instead of glass. Such tubes are thinner than glass tubes, thus increasing the internal volume and sample size. Such tubes are also more closely matched to the magnetic susceptibility of specific solvents. Such tubes have greater mechanical stability, thus leading to less tube breakage during NMR processing. Such tubes also lend themselves to various concentric tubal arrangements which permit separation and mixing of samples to minimize subtraction artifacts in interacting systems.
    Type: Grant
    Filed: July 30, 2004
    Date of Patent: July 11, 2006
    Assignee: Syracuse University
    Inventors: Michael J. Cavaluzzi, Philip N. Borer